RBC Capital Reiterates Outperform on HealthEquity, Maintains $108 Price Target

Benzinga Newsdesk www.benzinga.com Negative 88.9%

Neg 88.9% Neu 0% Pos 0%

RBC Capital analyst Ryan Halsted reiterates HealthEquity (NASDAQ:HQY) with a Outperform and maintains $108 price target.